Loading...

ABIVAX SA

AAVXFPNK
Healthcare
Biotechnology
$68.60
$1.46(2.17%)

ABIVAX SA (AAVXF) Financial Performance & Income Statement Overview

Review ABIVAX SA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
0.00%
Operating Income Growth
0.00%
Net Income Growth
0.00%
Operating Cash Flow Growth
-58.62%
58.62%
Operating Margin
-1602.89%
1602.89%
Gross Margin
100.00%
100.00%
Net Profit Margin
-1633.08%
1633.08%
ROE
-211.00%
211.000%
ROIC
-153.91%
153.91%

ABIVAX SA (AAVXF) Income Statement & Financial Overview

Review ABIVAX SA's (AAVXF) income statement with detailed quarterly and annual figures.

MetricQ2 2024Q4 2023Q3 2023Q2 2023
Revenue$6.79M$1.12M$1.12M$1.12M
Cost of Revenue$0.00$378000.00$0.00$329000.00
Gross Profit$6.79M$744500.00$1.12M$795000.00
Gross Profit Ratio$1.00$0.66$1.00$0.71
R&D Expenses$64.65M$35.28M$35.28M$32.62M
SG&A Expenses$22.16M$10.95M$10.95M$6.58M
Operating Expenses$86.78M$46.17M$47.80M$39.21M
Total Costs & Expenses$86.78M$46.17M$47.80M$39.53M
Interest Income$4.81M$0.00$1.22M$0.00
Interest Expense$7.89M$5.70M$0.00$14.70M
Depreciation & Amortization$171000.00$65000.00$65000.00$329000.00
EBITDA-$79.83M-$45.02M-$45.02M-$18.60M
EBITDA Ratio-$11.76-$40.11-$40.11-$34.88
Operating Income-$80.00M-$45.05M-$45.09M-$39.53M
Operating Income Ratio-$11.79-$40.13-$40.17-$35.17
Other Income/Expenses (Net)-$4.31M-$2.85M-$2.85M-$14.65M
Income Before Tax-$84.30M-$47.89M-$47.89M-$54.19M
Income Before Tax Ratio-$12.42-$42.67-$42.67-$48.21
Income Tax Expense-$2.67M-$2.26M$0.00-$2.23M
Net Income-$81.64M-$47.89M-$47.89M-$51.95M
Net Income Ratio-$12.03-$42.67-$42.67-$46.22
EPS-$1.30-$0.95-$0.95-$1.45
Diluted EPS-$1.30-$0.95-$0.95-$1.45
Weighted Avg Shares Outstanding$62.92M$50.23M$50.23M$35.90M
Weighted Avg Shares Outstanding (Diluted)$62.92M$50.23M$50.23M$35.90M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;